Experiment 67380
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | WILCOCK,GK: LILIENFIELD,S:. (2000). EFFICACY AND SAFETY OF GALANTAMINE IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE: MULTICENTRE RANDOMISED CONTROLLED TRAIL.. 321(7274) |
| Amount utilized | |
| Compound isolated | |
| Disease | RANDOMISED, DOUBLE BLIND, PARALLEL GROUP, PLACEBO CONTROLLED TRAIL. 643 PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE. PATIENTS RANDOMLY ASSIGNED TO GALANTHAMINE HAD THEIR DAILY DOSE ESCALATED VOER THREE TO FOUR WEEKS TO MAINTENANCE DOSES OF 24 TO 32 MG. AT SIX MONTHS, PATIENTS WHO RECEIVED GALANTHAMINE HAD A SIGNIFICANTLY BETTER OUTCOME ON THE 11 ITEM CONGNITIVE SUBSCALE OF THE ALZHEIMER'S DISEASE ASSESSMENT SCALE THAN PATIENTS IN THE PLACEBO GROUP. |
| Dose amount | VAR |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |